Japanese Pharmaceutical Rohto Mentholatum Group Launches in Kenya
Japanese Ambassador to Kenya H.E Toshitsugu Uesawa (second right), JICA Chief Representative to Kenya Ms. Keiko Sano (Right), Harleys Kenya Limited Managing Director Rupen Haria (left) and Rohto Mentholatum(K) Ltd Managing Director, Ms. Fumiko Akojima (second left) during the launch in Nairobi yesterday
- Rohto Mentholatum Group has launched operations in Kenya.
- The company is the second-largest consumer healthcare company in Japan
- Rohto Mentholatum Group’s products available in Kenya include Deep Heat and Acnes
- The company has unveiled a range of scalp care products called ROOTIA
Nairobi Kenya, Tues. December 6, 2016 – Leading Japanese Consumer Healthcare company, Rohto Mentholatum Group, has today launched its operations in Kenya, targeting to foray into the larger Eastern Africa region.
Rohto Mentholatum (K) brings innovation and a wealth of experience in the design and development of high-quality consumer healthcare products and cosmetics.
Through an initial investment of over KES100 million, the company will be headquartered in Nairobi with a view of providing strategic services in the healthcare and cosmetic sectors in the region.
Speaking during the launch, Rohto Mentholatum (K) Limited Country Director Ms. Fumiko Akojima said Kenya’s growing population provides a great opportunity for the company to advance its healthy living agenda.
“We have come to Kenya because we see it as a strategic gateway to East and Central Africa. Today’s launch marks a major milestone in Rohto Mentholatum Group’s heritage and mission,” said Ms. Akojima.
Ms. Akojima noted that company will largely focus on developing both the consumer healthcare and cosmetics industry in Kenya by introducing more innovative products tailored to suit specific needs in the marketplace.
“I am also privileged to introduce a range of scalp care products in Kenya called ROOTIA, and this is a great achievement for our company here today,” she said.
“ROOTIA brings a new and unique experience in scalp care and will give Kenyans an opportunity to grow healthy hair,” she said.
The launch of Rohto Mentholatum(K) and the unveiling of ROOTIA range of products comes in the wake of increased Japanese investments in Kenya, leveraging the long-term relationship thatthe countries have enjoyed over the past many years. The development also underscores Japan’s commitment to the $30 billion (KES 3 trillion) investment pledge to transform Africa that was made during the Tokyo International Conference on African Development (TICAD) conference last August.
“Japan has been heavily involved in transformational infrastructure projects in Kenya. The launch of Rohto Mentholatum Group in Kenya is a testimony of Japan’s commitment to fostering a healthy trading relationship with Kenya,” said JICA Kenya chief representative Ms. Keiko Sano.
During the 2016 TICAD, Kenya Investment Authority (KenInvest), a body mandated with promoting investments in Kenyarecorded more than 20 memoranda of understanding (MOUs), signed between Japanese companies, Kenya’s private sector and government institutions.
“Kenya is the fifth-largest economy south of the Sahara with educated, qualified and skilled youthful labor force,” said Dr. Moses Ikiara, KenInvest Managing Director.
“The Kenyan Government is building an enabling environment to attract investment and improve the ease of doing business,” Dr. Ikiara noted
Rohto Mentholatum is widely known in Kenya for its muscle pain reliever Deep Heat which is renown worldwide for its effectiveness. Recently, the company also introduced an acne solution called Acnes.
Global Network of Rohto-Mentholatum Group
Rohto Pharmaceutical Co. Ltd is the second-largest Consumer Healthcare Company in Japan. E Rohto started as a small family drugstore run by Yasutami Yamada in Osaka in 1889, Japan. The Company was a pioneer in over-the-counter medicines and consumer healthcare products.
In 1959, the current plant and Head Office were set up in Osaka. Over the years, Rohto Pharmaceutical Co. Ltd has established on the list of world leaders in manufacturing and marketing of pharmaceuticals, cosmetics, skin care and health care products.
Mentholatum was founded in 1889 in Wichitam Kansas, USA, as small purveyor of soaps and toiletries. The company grew into an international manufacturer and marketer of non-prescription drugs with a reputation for quality and value. In 1988, Rohto Pharmaceutical Company, Ltd. acquired the Mentholatum Company Inc.
Today, the combined Rohto Mentholatum Group has established 23 companies worldwide with products available to customers in more than 130 countries. Globally, the Group has marketing and distribution agreements with hundreds of reputed corporations in more than 110 countries today. We are proud that the ROHTO and Mentholatum names are now synonymous with the highest standards of quality and innovation in consumer healthcare.
Rohto Mentholatum (Kenya) Ltd was incorporated in Kenya in May 2013 with the aim of expanding the Group’s network in Africa. Rohto Mentholatum (K) Ltd is founded on a mission to develop the pharmaceutical and cosmetics industry in Kenya and the East African Region.